Bank of New York Mellon Corp
BankPosition in RIGL — Rigel Pharmaceuticals Inc
CIK 1390777
NEW YORK, NY
Position in RIGL
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$4,233,133
+$1,531,190 QoQ
Shares Held
108,209
+8.3% QoQ
Ownership
0.579%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 156 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in RIGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. RIGL ranks #107 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in RIGL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,233,133 | 108,209 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $2,701,943 | 99,924 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $4,637,031 | 108,266 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $2,772,401 | 97,861 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $1,742,544 | 93,035 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $891,798 | 49,572 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $844,278 | 50,195 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $736,561 | 45,523 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $489,081 | 59,499 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $775,543 | 524,016 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $820,625 | 565,949 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $602,706 | 558,062 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $733,027 | 568,239 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $735,029 | 556,841 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $846,967 | 564,645 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $671,079 | 568,712 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $591,677 | 523,609 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,655,325 | 553,621 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $1,463,260 | 552,174 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,967,513 | 542,015 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $2,221,797 | 511,935 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $2,117,530 | 619,161 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $2,344,846 | 669,956 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $1,617,914 | 674,131 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,254,429 | 685,481 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,074,735 | 688,933 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||